Table 1.
Biocides | Microorganisms under experiment | Cross-resistance/cross tolerance pattern | References |
---|---|---|---|
Benzalkonium chloride | E. coli | Decreased susceptibility to cotrimoxazole. Expression of MdtM multi-drug efflux pump. |
(Holdsworth and Law, 2013) |
Pseudomonas spp. | Resistance to ampicillin, amoxicillin, erythromycin, and trimethoprim. Induction of MexCD-OprJ multi-drug efflux pump. |
(Bataillon et al., 2011; Lerma et al., 2015; Morita et al., 2003) | |
Salmonella typhimurium | High tolerance to chloramphenicol, tetracycline, ampicillin. Overexpression of AcrAB or AcrEF acriflavine efflux pump. | (Guo et al., 2014; Karatzas et al., 2007) | |
Chlorhexidine digluconate | E. coli, S. aureus, S. haemolyticus | Increase in HGT of MGE carrying ARGs. | (Jutkina et al., 2018) |
Pseudomonas spp. | Co-resistance to ciprofloxacin, norfloxacin, tobramycin, gentamicin, ampicillin, polymyxin, and erythromycin. Reduced adsorption of biocide to the cell surface and induction of MexCD-OprJ multi-drug efflux pump. |
(Gajadhar et al., 2003; Morita et al., 2003; Nagai et al., 2003; Tattawasart et al., 1999) | |
A. baumannii | Co-resistance to carbapenem, aminoglycoside, tetracycline, and ciprofloxacin. Increased expression of multiple efflux pump genes. |
(Cuenca et al., 2015) | |
Triclosan | E. coli | Enhance of efflux pump system. Increase in HGT of MGE carrying ARGs. |
(Jutkina et al., 2018; Sonbol et al., 2019) |
Acinetobacter johnsonii | Decreased susceptibility with chloramphenicol. | (Lear et al., 2002) | |
Pseudomonas spp. | Cross-tolerance with ampicillin, amoxicillin, erythromycin, imipenem, and trimethoprim. | (Lerma et al., 2015) | |
Salmonella spp. | Reduced susceptibility to chloramphenicol, tetracycline, ampicillin et cetera. Overexpression of AcrAB acriflavine efflux pump. |
(Karatzas et al., 2007) | |
Didecyldimethylammonium chloride | E. coli | Decreased sensitivity to cotrimoxazole and amoxicillin. | (Bataillon et al., 2011) |
Sodium hypochlorite | Salmonella spp. | Cross-resistance with class aminoglycosides and cephalosporins, amikacin, ampicillin, chloramphenicol, tetracycline, and teicoplanin. | (González et al., 2014) |